220 related articles for article (PubMed ID: 8604712)
1. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney.
Benigni A; Zola C; Corna D; Orisio S; Facchinetti D; Benati L; Remuzzi G
Am J Kidney Dis; 1996 Mar; 27(3):416-23. PubMed ID: 8604712
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
[TBL] [Abstract][Full Text] [Related]
3. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
[TBL] [Abstract][Full Text] [Related]
4. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A
Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
[TBL] [Abstract][Full Text] [Related]
5. An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis.
Gómez-Garre D; Largo R; Liu XH; Gutierrez S; López-Armada MJ; Palacios I; Egido J
Kidney Int; 1996 Sep; 50(3):962-72. PubMed ID: 8872972
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.
Cao Z; Cooper ME; Wu LL; Cox AJ; Jandeleit-Dahm K; Kelly DJ; Gilbert RE
Hypertension; 2000 Oct; 36(4):561-8. PubMed ID: 11040236
[TBL] [Abstract][Full Text] [Related]
7. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
8. Paracrine renal endothelin system in rats with liver cirrhosis.
Hocher B; Zart R; Diekmann F; Rohmeiss P; Distler A; Neumayer HH; Bauer C; Gross P
Br J Pharmacol; 1996 May; 118(2):220-7. PubMed ID: 8735618
[TBL] [Abstract][Full Text] [Related]
9. Significance of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats: renal and hemodynamic effects of endothelin receptor antagonists.
Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S470-2. PubMed ID: 8587449
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function.
Forbes JM; Hewitson TD; Becker GJ; Jones CL
Kidney Int; 2001 Apr; 59(4):1333-41. PubMed ID: 11260394
[TBL] [Abstract][Full Text] [Related]
11. Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats.
Shimizu T; Hata S; Kuroda T; Mihara S; Fujimoto M
Eur J Pharmacol; 1999 Sep; 381(1):39-49. PubMed ID: 10528132
[TBL] [Abstract][Full Text] [Related]
12. Endothelin ET
Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
[TBL] [Abstract][Full Text] [Related]
13. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
Rothermund L; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2003 Dec; 21(12):2389-97. PubMed ID: 14654760
[TBL] [Abstract][Full Text] [Related]
14. Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats.
Vanêcková I; Kramer HJ; Bäcker A; Vernerová Z; Opocensky M; Cervenka L
Hypertension; 2005 Oct; 46(4):969-74. PubMed ID: 16157796
[TBL] [Abstract][Full Text] [Related]
15. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
[TBL] [Abstract][Full Text] [Related]
16. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
Seo B; Lüscher TF
Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
[TBL] [Abstract][Full Text] [Related]
18. Endothelin and endothelin antagonists in hypertension.
Schiffrin EL
J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
[TBL] [Abstract][Full Text] [Related]
19. Renal endothelin system in polycystic kidney disease.
Hocher B; Zart R; Schwarz A; Vogt V; Braun C; Thöne-Reineke C; Braun N; Neumayer HH; Koppenhagen K; Bauer C; Rohmeiss P
J Am Soc Nephrol; 1998 Jul; 9(7):1169-77. PubMed ID: 9644626
[TBL] [Abstract][Full Text] [Related]
20. Unfavorable Reduction in the Ratio of Endothelin B to A Receptors in Experimental 5/6 Nephrectomy and Adenine Models of Chronic Renal Insufficiency.
Törmänen S; Lakkisto P; Eräranta A; Kööbi P; Tikkanen I; Niemelä O; Mustonen J; Pörsti I
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
